Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
Asahi
Hideki
H
Yatsuo General Hospital, Toyama, Japan.
Mizokami
Atushi
A
Maeda
Yuji
Y
Komatsu
Kazuto
K
Koshida
Kiyoshi
K
Namiki
Mikio
M
D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000556:secondary*; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000097:blood / Q000188:drug therapy / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D004359:Drug Therapy, Combination; D004961:Estramustine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000473:pathology*
D018931:Antineoplastic Agents, Hormonal; D004164:Diphosphonates; C071542:cimadronate; D004961:Estramustine; D017430:Prostate-Specific Antigen